HTRA3

Chr 4

HtrA serine peptidase 3

Also known as: Prsp, Tasp

The protein is a serine protease that cleaves extracellular matrix components including decorin, biglycan, and fibronectin, and may inhibit TGF-beta signaling. Biallelic mutations cause autosomal recessive cerebral arteriopathy with subcortical infarcts and leukoencephalopathy (CARASIL), characterized by progressive subcortical vascular dementia, alopecia, and skeletal abnormalities typically beginning in adulthood. The gene shows tolerance to loss-of-function variants in the general population.

Summary from RefSeq, UniProt
Research Assistant →
0
Active trials
4
Pubs (1 yr)
74
P/LP submissions
0%
P/LP missense
1.23
LOEUF
Multiple*
Mechanism· predicted
Clinical SummaryHTRA3
Population Constraint (gnomAD)
Low constraint (pLI 0.00) — loss-of-function variants are relatively tolerated in the population.
📋
ClinVar Variants
74 unique Pathogenic / Likely Pathogenic· 87 VUS of 172 total submissions

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Tolerant — LoF & missense variants common in population
LoF Constraint
1.23LOEUF
pLI 0.000
Z-score 0.85
OE 0.78 (0.501.23)
Tolerant

Highly tolerant — LoF variants common in population

Missense Constraint
0.50Z-score
OE missense 0.91 (0.821.02)
243 obs / 265.8 exp
Tolerant

Mild missense constraint

Observed / Expected Ratios
LoF OE0.78 (0.501.23)
00.351.4
Missense OE0.91 (0.821.02)
00.61.4
Synonymous OE1.02
01.21.6
LoF obs/exp: 13 / 16.8Missense obs/exp: 243 / 265.8Syn Z: -0.18
DN
0.7228th %ile
GOF
0.6639th %ile
LOF
0.3551th %ile

This gene has evidence for multiple mechanisms of pathogenicity (dominant-negative and gain-of-function). Both the Badonyi & Marsh prediction and the broader genomic evidence point to dominant-negative as the predominant mechanism. Different variants in this gene may act through different mechanisms — interpret in context of the specific variant.

DNprediction above median
GOFprediction above median

Note: In-silico variant effect predictors (SIFT, PolyPhen, REVEL, CADD) may underestimate pathogenicity of missense variants in genes with GOF or DN mechanisms. Consider functional evidence and clinical context.

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312.

ClinVar Variant Classifications

172 submitted variants in ClinVar

Classification Summary

Pathogenic71
Likely Pathogenic3
VUS87
Likely Benign4
Benign1
71
Pathogenic
3
Likely Pathogenic
87
VUS
4
Likely Benign
1
Benign

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
0
0
71
0
71
Likely Pathogenic
0
0
3
0
3
VUS
0
80
7
0
87
Likely Benign
0
1
2
1
4
Benign
0
1
0
0
1
Total082831166

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

Protein Context — Lollipop Plot

HTRA3 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

3D Protein StructureAlphaFold

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →
Clinical Literature
Open Research Assistant →